Skip to content

Ayesha Abbasi, MD

NPI 1376216705ActiveIndividual· Internal Medicine· Chicago, IL

Internal Medicine (MD) in Chicago, Illinois, licensed in IL, with an NPI issued in July 2021. Part D covered 111 prescriptions written in 2024, 73% of them generic. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 7 companies reporting payments in 2025, $251.06 in all, mostly food and beverage.

Overview

NPI1376216705
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 30, 2021
Last updated in NPPESJul 30, 2021
Certified by providerJul 30, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X125077685IL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Cardiovascular Disease (Cardiology) (IL)

Part D prescriptions in 2024

Prescriptions (claims)111 · 276 30-day fills
Patients31
Total drug cost$23,435
Generic share73% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$251.06 · 11 payments from 7 companies
  • 2024$70.56 · 3 payments from 2 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$251.06 · 11 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Chicago

All Internal Medicine providers in Illinois →